336
Views
55
CrossRef citations to date
0
Altmetric
Research Article

MITOCHONDRIAL DYSFUNCTION IN T CELLS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

, &
Pages 293-313 | Published online: 03 Aug 2009

REFERENCES

  • K.B., Elkon. Apoptosis in SLE—too little or too much?. Clin. Exper. Rheum.. 12: 553–559, 1994, [CSA]
  • A., Perl, K., Banki. Molecular mimicry altered apoptosis, and immunomodulation as mechanisms of viral pathogenesis in systemic lupus erythematosus. G.M., Kammer, G.C., Tsokos. Lupus Molecular and Cellular Pathogenesis. Totowa, NJ, Humana Press. 43–64, 1999
  • J.J., Cohen, R.C., Duke, V.A., Fadok, K.S., Sellins. Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol.. 10: 267–293, 1992, [CSA], [CROSSREF]
  • C.B., Thompson. Apoptosis in the pathogenesis and treatment of disease. Science. 267: 1456–1462, 1995
  • W., Emlen, J.A., Niebur, R., Kadera. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol.. 152: 3685–3692, 1994
  • L.A., Casciola-Rosen, G., Anhalt, A., Rosen. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med.. 179: 1317–1330, 1994, [CROSSREF]
  • B., Kovacs, D., Vassilopoulos, S.A., Vogelgesang, G.C., Tsokos. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-alpha. Clin. Immunol. Immunopathol.. 81: 293–302, 1996, [CSA], [CROSSREF]
  • M., Lenardo, K.M., Chan, F., Hornung, H., McFarland, R., Siegel, J., Wang. Mature T lymphocyte apoptosis—immune regulation in a dynamic and unpredictable antigenic environment. Ann. Rev. Immunol.. 17: 221–253, 1999, [CSA], [CROSSREF]
  • V.P., Skulachev. Mitochondrial physiology and pathology; Concepts of programmed death of organelles, cells and organisms. Mol Aspects Med.. 20: 139–140, 1999, [CSA], [CROSSREF]
  • J., Xiang, D.T., Chao, S.J., Korsmeyer. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93: 14559–14563, 1996, [CSA], [CROSSREF]
  • S.A., Susin, N., Zamzami, M., Castedo, E., Daugas, H.-G., Wang, S., Geley. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J Exp. Med.. 186: 25–37, 1997, [CROSSREF]
  • M., Vander Heiden, N.S., Chandel, E.K., Williamson, P.T., Schumaker, C.B., Thompson. Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91: 627–637, 1997, [CROSSREF]
  • P., Constantini, B.V., Chernyak, V., Petronilli, P., Bernardi. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem.. 271: 6746–6751, 1996, [CROSSREF]
  • P.A., Mayes. The pentose phosphate pathway & other pathways of hexose metabolism. R.K., Murray, D.K., Granner, P.A., Mayes, V.W., Rodwell. Harper's Biochemistry. Norwalk, CT, Appleton & Lange. 201–211, 1993
  • K., Banki, E., Hutter, E., Colombo, N.J., Gonchoroff, A., Perl. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem.. 271: 32994–33001, 1996, [CROSSREF]
  • K., Banki, E., Hutter, N., Gonchoroff, A., Perl. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol.. 162: 1466–1479, 1999
  • S.A., Lipton, Y.-B., Choi, Z.-H., Pan, S.Z., Lei, H.-S.V., Chen, N.J., Sucher. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364: 626–631, 1993, [CROSSREF]
  • B., Halliwell, J.M., Gutteridge. Role of free radicals and catalytic metal ions in human disease: An overview. Meth. Enzymol.. 186: 1–85, 1990
  • J.S., Stamler. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell. 78: 931–936, 1994, [CROSSREF]
  • S.J., Korsmeyer. Regulators of cell death. Trends Genet.. 11: 101–105, 1995, [CSA], [CROSSREF]
  • T.M., Buttke, P.A., Sandstrom. Oxidative stress as a mediator or apoptosis. Immunol. Today. 15: 7–10, 1994, [CSA], [CROSSREF]
  • D.L., Hamilos, H.J., Wedner. The role of glutathione in lymphocyte activation. 1. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene- 1-one by nuclear size transformation. J. Immunol.. 135: 2740–2747, 1985
  • M., Los, W., Droge, K., Stricker, P.A., Bauerle, K., Schulze-Osthoff. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol.. 25: 159–165, 1995, [CSA]
  • A., Perl, K., Banki. Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease. Antiox. Redox. Signal.. 2: 551–573, 2000, [CSA], [CROSSREF]
  • M., Suthanthiran, M.E., Anderson, V.K., Sharma, A., Meister. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. USA. 87: 3343–3347, 1990, [CSA]
  • G.A., Koretzky, N.J., Boerth. The role of adapter proteins in T cell activation. Cell. Mol. Life Sci.. 56: 1048–1060, 1999, [CSA], [CROSSREF]
  • M., Otsuji, Y., Kimura, T., Aoe, Y., Okamoto, T., Saito. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. USA. 93: 13119–13124, 1996, [CSA], [CROSSREF]
  • S.I., Gringhuis, A., Leow, E.A., Papendrecht-Van Der Voort, P.H., Remans, F.C., Breedveld. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J. Immunol.. 164: 2170–2179, 2000
  • R., Gopalakrishna, S., Jaken. Protein kinase C signaling and oxidative stress. Free Radical Biol. Med.. 28: 1349–1361, 2000, [CSA], [CROSSREF]
  • M., Lucas, V., Sanchez-Margalet. Protein kinase C involvement in apoptosis. Gen. Pharmac.. 26: 881–887, 1995, [CSA]
  • L., Beiqing, M., Chen, R.L., Whisler. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells. J. Immunol.. 157: 160–169, 1996
  • K., Furuke, M., Shiraishi, H.S., Mostowski, E.T., Bloom. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J. Immunol.. 162: 1988–1993, 1999
  • S., Saccani, A., Saccani, L., Varesio, P., Ghosh, H.A., Young, A., Sica. Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites. Eur. J. Immunol.. 29: 1194–1201, 1999, [CSA], [CROSSREF]
  • J., Abe, B.C., Berk. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J. Biol. Chem.. 274: 21003–21010, 1999, [CROSSREF]
  • J., Abe, M., Takahashi, M., Ishida. J.D. Lee, and B.C. Berk, c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase I. J Biol. Chem.. 272: 20389–20394, 1997, [CROSSREF]
  • A.A., Deora, T., Win, B., Vanhaesebroeck, H.M., Lander. A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J. Biol. Chem.. 273: 29923–29928, 1998, [CROSSREF]
  • S.P., Hehner, R., Breitkreutz, G., Shubinsky, H., Unsoeld, K., Schulze-Osthoff, M.L., Schmitz. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J. Immunol.. 165: 4319–4328, 2000
  • M., Yoshizumi, J., Abe, J., Haendeler, Q., Huang, B.C., Berk. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J. Biol. Chem.. 275: 11706–11712, 2000, [CROSSREF]
  • S., Qin, T., Inazu, M., Takata, T., Kurosaki, Y., Homma, H., Yamamura. Cooperation of tyrosine kinases p72syk and p53/56lyn regulates calcium mobilization in chicken B cell oxidant stress signaling. Eur. J. Biochem.. 236: 443–449, 1996, [CROSSREF]
  • M.E., Ginn-Pease, R.L., Whisler. Redox signals and NF-kappaB activation in T cells. Free Radical Biol. Med.. 25: 346–361, 1998, [CSA], [CROSSREF]
  • H., Nakamura, K., Nakamura, J., Yodoi. Redox regulation of cellular activation. Ann. Rev. Immunol.. 15: 351–369, 1997, [CSA], [CROSSREF]
  • W.N., Tian, L.D., Braunstein, J., Pang, K.M., Stuhlmeier, Q.C., Xi, R.C., Stanton. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J. Biol. Chem.. 273: 10609–10617, 1998, [CROSSREF]
  • K., Banki, E., Hutter, N.J., Gonchoroff, A., Perl. Molecular ordering in HIV-induced apoptosis: Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J Biol. Chem.. 273: 11944–11953, 1998, [CROSSREF]
  • M.V., Ursini, A., Parrella, G., Rosa, S., Salzano, G., Martini. Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress. Biochem. J.. 323: 801–806, 1997
  • J., Piette, B., Piret, G., Bonizzi, S., Schoonbroodt, M.P., Merville, S., Legrand-Poels. Multiple redox regulation in NF-kappaB transcription factor activation. Biol. Chem.. 378: 1237–1245, 1997, [CSA]
  • V., Imbert, R.A., Rupec, A., Livolsi, H.L., Pahl, E.B., Traenckner, C., Mueller-Dieckmann. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell. 86: 787–798, 1996, [CROSSREF]
  • K.N., Schmidt, P., Amstad, P., Cerutti, P.A., Baeuerle. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem. Biol.. 2: 13–22, 1995, [CSA], [CROSSREF]
  • E.B., Traenckner, P.A., Baeuerle. Appearance of apparently ubiquitin- conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells. J. Cell Sci.-Suppl.. 19: 79–84, 1995, [CSA]
  • N., Li, N., Karin. Is NF-kB the sensor of oxidative stress?. FASEB J.. 13: 1137–1143, 1999, [CSA]
  • C., Kretz-Remy, E.E., Bates, A.P., Arrigo. Amino acid analogs activate NF- kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-I long terminal repeat activation. J. Biol. Chem.. 273: 3180–3191, 1998, [CROSSREF]
  • T., Okamoto, H., Ogiwara, T., Hayashi, A., Mitsui, T., Kawabe, J., Yodoi. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type I by thiol redox control mechanism. Internat. Immunol.. 4: 811–819, 1992
  • T., Hayashi, Y., Ueno, T., Okamoto. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem.. 268: 11380–11388, 1993
  • W., Droge, K., Schulze-Osthoff, S., Mihm, D., Galter, H., Schenk, H.P., Eck. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J.. 8: 1131–1138, 1994, [CSA]
  • T., Okamoto, S., Sakurada, J.P., Yang, J.P., Merin. Regulation of NF-kappa B and disease control: Identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation. Curr. Topics Cell. Regulation. 35: 149–161, 1997, [CSA]
  • J.R., Matthews, N., Wakasugi, J.L., Virelizier, J., Yodoi, R.T., Hay. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucl. Acids. Res.. 20: 3821–3830, 1992
  • D., Galter, S., Mihm, W., Droge. Distinct effects of glutathione disulphide on the transcription factors NFkB and AP-1. Eur. J. Biochem.. 221: 639–648, 1994, [CROSSREF]
  • S., Nagata. Apoptosis by death factor. Cell. 88: 355–365, 1997, [CROSSREF]
  • N., Itoh, S., Nagata. A novel protein domain required for apoptosis: Mutational analysis of human Fas antigen. J. Biol. Chem.. 268: 10932–10937, 1993
  • L.A., Tartaglia, T.M., Ayres, G.H.W., Wong, G.V., Goeddel. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74: 845–853, 1993, [CROSSREF]
  • M., Tewari, V.M., Dixit. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the Poxvirus crmA gene product. J. Biol. Chem.. 270: 3255–3260, 1995, [CROSSREF]
  • M., Los, M., Van de Craen, L.S., Penning, H., Schenk, M., Westendorp, P.A., Baeuerle. Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apoptosis. Nature. 375: 81–83, 1995, [CROSSREF]
  • M., Enari, H., Hug, S., Nagata. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375: 78–81, 1995, [CROSSREF]
  • S.J., Martin, D.R., Green. Protease activation during apoptosis: death by a thousand cuts. Cell. 82: 349–352, 1995, [CROSSREF]
  • M.P., Boldin, T.M., Goncharov, Y.V., Goltsev, D., Wallach. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/Apo-1- and TNF receptor-induced cell death. Cell. 85: 803–815, 1996, [CROSSREF]
  • M., Muzio, A.M., Chinnaiyan, F.C., Kischkel, K., O'Rourke, A., Shevchenko, J., Ni. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 [Fas/Apo1] death-inducing signaling complex. Cell. 85: 817–827, 1996, [CROSSREF]
  • M., Thome, P., Schneider, K., Hofman, H., Fickenscher, E., Meinl, F., Neipel. Viral FLICE-inhibitory proteins [FLIPs] prevent apoptosis induced by death receptors. Nature. 386: 517–521, 1997, [CROSSREF]
  • J., Bertin. Death effector domain-containing herpesvirus and poxvirus proteins inhibit Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94: 1172–1176, 1997, [CSA], [CROSSREF]
  • A., Algeciras-Schimnich, T.S., Griffith, D.H., Lynch, C.V., Paya. Cell cycle- dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol.. 162: 5205–5211, 1999
  • B., Meier, H.H., Radeke, S., Selle, M., Younes, H., Sies, K., Resch. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α. Biochem. J.. 263: 539–545, 1989, [CSA]
  • T., Hennet, C., Richter, E., Peterhans. Tumor necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells. Biochem. J.. 289: 587–592, 1993
  • K., Schulze-Osthoff, P.H., Krammer, W., Droge. Divergent signaling via APO-1/Fas and the TNFreceptor, two homologous molecules involved in physiological cell death. EMBO J.. 13: 4587–4596, 1994, [CSA]
  • Y., Kasahara, K., Iwai, A., Yachie, K., Ohta, A., Konno, H., Seki. Involvement of reactive oxygen intermediates in spontaneous and CD95 [Fas/APO–1]-mediated apoptosis of neutrophils. Blood. 89: 1748–1753, 1997, [CSA]
  • M.S., Williams, P.A., Henkart. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol.. 157: 2395–2402, 1996
  • E., Gulbins, B., Brenner, K., Schlottmann, J., Welsch, H., Heinle, U.L., Koppenhoefer. Fas-induced programmed cell death is mediated by a Ras-regulated O2- synthesis. Immunology. 89: 205–212, 1996, [CROSSREF]
  • H.D., Um, J.M., Orenstein, S.M., Wahl. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J. Immunol.. 156: 3469–3477, 1996
  • F., Puskas, P., Gergely, K., Banki, A., Perl. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J.. 14: 1352–1361, 2000, [CSA], [CROSSREF]
  • P.-F., Li, R., Dietz, R., von. Harsdorf, p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by bcl-2. EMBO J.. 18: 6027–6036, 1999, [CSA], [CROSSREF]
  • E., Gottlieb, M.G., Vander Heiden, C.B., Thompson. Bcl-XL prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell. Biol.. 20: 5680–5689, 2000, [CROSSREF]
  • J.L., Scarlett, P.W., Sheard, G., Hughes, E.C., Ledgerwood, H.-H., Ku, M.P., Murphy. Changes in mitochondrial membrane potential during staurosporin-induced apoptosis in Jurkat cells. FEBS Lett.. 475: 267–272, 2000, [CSA], [CROSSREF]
  • G.S., Salvesen, V.M., Dixit. Caspases: Intracellular signaling by proteolysis. Cell. 91: 443–446, 1997, [CROSSREF]
  • A., Gross, J.M., McDonnell, S.J., Korsmeyer. BCL-2 family members and the mitochondria in apoptosis. Genes Dev.. 13: 1899–1911, 1999
  • P.J., Gergely, C., Grossman, B., Niland, F., Puskas, H., Neupane, F., Allam. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arth. Rheum.. 46: 175–190, 2001
  • P.J., Gergely, B., Niland, N., Gonchoroff, R., Pullmann. Jr.  P.E. Phillips, and A. Perl. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J. Immunol.. 169: 1092–1101, 2002
  • L., Stryer. Biochemistry 3rd. New York, W.H. Freeman and Company. 1988
  • P., Li, D., Nijhawan, I., Budihardjo, S.M., Srinivasula, M., Ahmad, E.S., Alnemri. Cytochrome c and dATP-depedent formation of Apaf-1/Caspase-9 complex initiates and apoptotic protease cascade. Cell. 91: 479–489, 1997, [CROSSREF]
  • M., Barkett, D., Xue. H.R. Horvitz, and T.D. Gilmore. Phosphorylation of IkB-α inhibits its cleavage by caspase CPP32 in vitro. J Biol. Chem.. 272: 29419–29422, 1997, [CROSSREF]
  • Y., Emoto, Y., Manome, G., Meinhardt, H., Kisaki, S., Kharbanda, M., Robertson. Proteolytic activation of protein kinase C d by an ICE-like protease in apoptotic cells. EMBO J.. 14: 6148–6156, 1995, [CSA]
  • R., Datta, H., Kojima, K., Yoshida, D., Kufe. Caspase-3-mediated cleavage of protein kinase C O in induction of apoptosis. J. Biol. Chem.. 272: 20317–20320, 1997, [CROSSREF]
  • M., Enari, H., Sakahira, H., Yokoyama, K., Okawa, A., Iwamatsu, S., Nagata. A capase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391: 43–50, 1998, [CROSSREF]
  • D.R., Green, J.C., Reed. Mitochondria and apoptosis. Science. 281: 1309–1312, 1998, [CROSSREF]
  • H., Harada, B., Becknell, M., Wilm, M., Mann, L.J., Huang, S.S., Taylor. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell. 3: 413–422, 1999, [CROSSREF]
  • J., Yang, X., Liu, K., Bhalla, C.N., Kim, A.M., Ibrado, J., Cai. Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked. Science. 275: 1129–1132, 1997, [CROSSREF]
  • R.M., Kluck, E., Bossy-Wetzel, D.R., Green, D.D., Newmeyer. The release of cytochrome c from mitochondria: A primary site for bcl-2 regulation of apoptosis. Science. 275: 1132–1136, 1997, [CROSSREF]
  • M., Leist, B., Single, A.F., Castoldi, S., Kuhnle, P., Nicotera. Intracellular adenosine triphosphate [ATP] concentration: A switch in the decision between apoptosis and necrosis. J Exp. Med.. 185: 1481–1486, 1997, [CROSSREF]
  • Y., Lee, E., Shacter. Oxidative stress inhibits apoptosis in human lymphoma cells. J. Biol. Chem.. 274: 19792–19798, 1999, [CROSSREF]
  • S.C., Chow, G.E.N., Kass, S., Orrenius. Purine and their role in apoptosis. Neuropharmacology. 36: 1149–1156, 1997, [CSA], [CROSSREF]
  • R.S., Lewis. Calcium signaling mechanisms in T lymphocytes. Ann. Rev. Immunol.. 19: 497–521, 2001, [CSA], [CROSSREF]
  • K.F., LaNoue, J., Duszynski. Kinetic studies of ATP synthase: the case for the positional change mechanism. J. Bioenergetics Biomembranes. 24: 499–506, 1999, [CSA]
  • D.J., McConkey, S., Orrenius. The role of calcium in the regulation of apoptosis. J. Leukocyte Biol.. 59: 775–783, 1996, [CSA]
  • S., Nagata, P., Golstein. The Fas death factor. Science. 267: 1449–1456, 1995
  • G.H., Fisher, F.J., Rosenberg, S.E., Straus, J.K., Dale, L.A., Middleton, A.Y., Lin. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81: 935–946, 1995, [CROSSREF]
  • J., Drappa, A.K., Vaishnaw, K.E., Sullivan, J.-L., Chu, K.B., Elkon. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl. J. Med.. 335: 1643–1649, 1996, [CSA], [CROSSREF]
  • F., Salvemini, A., Franze, A., Iervolino, S., Filosa, S., Salzano, M.V., Ursini. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J. Biol. Chem.. 274: 2750–2757, 1999, [CROSSREF]
  • O., Le Moine, H., Louis, P., Stordeur, J.M., Collet, M., Goldman, J., Deviere. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology. 113: 1701–1706, 1997
  • M., al Janadi, S., al Balla, A., al Dalaan, S., Raziuddin. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J. Clin. Immunol.. 13: 58–67, 1993, [CROSSREF]
  • A., Studnicka-Benke, G., Steiner, P., Petera, J.S., Smolen. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Brit. J. Rheum.. 35: 1067–1074, 1996, [CSA]
  • A.J., Swaak. H.G. van den Brink, and L.A. Aarden, Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J. Rheum.. 25: 233–238, 1996
  • B.S., Handwerger, I., Luzina, L., Da Silva, C.E., Storrer, C.S., Via. Cytokines in the immunopathogenesis of lupus. G.S., Kammer, G.C., Tsokos. Lupus Molecular and cellular pathogenesis. Totowa, NJ, Humana. 321–340, 1999
  • S.N., Liossis, X.Z., Ding, G.J., Dennis, G.C., Tsokos. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest.. 101: 1448–1457, 1998, [CSA]
  • D., Li, B., Yang, J.L., Mehta. Ox-LDL induces apoptosis in human coronary artery endothelial cells: Role of PKC PTK, bcl-2, and Fas. Am. J. Physiol.. 275: H568–H576, 1998
  • J.R., Orlinick, A., Vaishnaw, K.B., Elkon, M.V., Chao. Requirement of cysteine-rich repeats of the Fas receptor for binding of the Fas ligand. J. Biol. Chem.. 272: 28889–28894, 1997, [CROSSREF]
  • M., Bennett, K., Macdonald, S-W., Chan, J.P., Luzio, R., Simari, P., Weissberg. Cell surface trafficking of Fas A rapid mechanism of p53-induced apoptosis. Science. 282: 290–293, 1998
  • S., Kasibhatla, L., Genestier, D.R., Green. Regulation of Fas ligand expression during activation-induced cell death in T lymphocytes. J. Biol. Chem.. 274: 987–992, 1999, [CROSSREF]
  • J., He, S., Choe, R., Walker, P., Di. Marzio, D.O. Morgan, and N.R. Landau, Human immunodeficiency virus type 1 viral protein R [vpr] arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol.. 69: 6705–6711, 1995, [CSA]
  • H.M., Lorenz, M., Grunke, T., Hieronymus, M., Herrmann, A., Kuhnel, B., Manger. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arth. Rheum.. 40: 306–317, 1997
  • L., Georgescu, R.K., Vakkalanka, K.B., Elkon, M.K., Crow. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest.. 100: 2622–2633, 1997, [CSA]
  • J.C., Oates, E.F., Christensen, C.M., Reilly, S.E., Self, G.S., Gilkeson. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: Correlation with disease activity. Proc. Assoc. Am. Phys.. 111: 611–621, 1999, [CSA], [CROSSREF]
  • G.S., Cooper, M.A., Dooley, E.L., Treadwell, E.W., St.Clair, C.G., Parks, G.S., Gilkeson. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arth. Rheum.. 41: 1714–1724, 1998, [CROSSREF]
  • W., Fiers, R., Beyaert, W., Declercq, P., Vandenabeele. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 18: 7719–7730, 1999, [CSA], [CROSSREF]
  • I., Lorand-Metze, M.A., Carvalho, L.T., Costallat. Morphology of bone marrow in systemic lupus erythematosus. Pathologe. 15: 292–296, 1994 (in German), [CSA], [CROSSREF]
  • Y.H., Ko, J., Dal Lee. Fine needle aspiration cytology in lupus lymphadenopathy. A case report. Acta Cytologica. 36: 748–751, 1992
  • M.D., Eisner, J., Amory, B., Mullaney, L., Tierney, Jr., W.S., Browner. Necrotizing lymphadenitis associated with systemic lupus erythematosus. Seminars Arth. Rheum.. 26: 477–482, 1996, [CSA], [CROSSREF]
  • K., Virdee, P.A., Parone, A.M., Tolkovsky. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr. Bio.. 10: 1151–1154, 2000, [CROSSREF]
  • B.R., Lauwerys, N., Garot, J.C., Renauld, F.A., Houssiau. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arth. Rheum.. 43: 1976–1981, 2000, [CROSSREF]
  • K., Ohtsuka, J.D., Gray, M.M., Stimmler, B., Toro, D.A., Horwitz. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J. Immunol.. 160: 2539–2545, 1998
  • G.C., Tsokos, S.-N.C., Liossis. Immune cell signaling defects in lupus: activation, anergy and death. Immunol. Today. 20: 119–124, 1999, [CSA], [CROSSREF]
  • G.M., Kammer. High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus. Arth. Rheum.. 42: 1458–1465, 1999, [CROSSREF]
  • N., Mishra, I.U., Khan, G.C., Tsokos, G.M., Kammer. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes. J Immunol.. 165: 2830–2840, 2000
  • J.M., Lizcano, N., Morrice, P., Cohen. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J.. 349: 547–557, 2000, [CSA], [CROSSREF]
  • Y., Tan, M.R., Demeter, H., Ruan, M.J., Comb. BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J. Biol. Chem.. 275: 25865–25869, 2000, [CROSSREF]
  • X.M., Zhou, Y., Liu, G., Payne, R.J., Lutz, T., Chittenden. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J. Biol. Chem.. 275: 25046–25051, 2000, [CROSSREF]
  • C.K., Sen, L., Packer. Antioxidant and redox regulation of gene transcription [see comments]. FASEB J.. 10: 709–720, 1996, [CSA]
  • L., Llorente, W., Zou, Y., Levy, Y., Richaud-Patin, J., Wijdenes, J., Alcocer-Varela. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med.. 181: 839–844, 1995, [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.